Valuation: Sernova Biotherapeutics Inc

Market Cap 41.54M 29.47M 26.43M 24.15M 22.05M 2.77B 42.85M 291M 116M 1.48B 111M 108M 4.67B P/E 2026 *
-4.4x
P/E 2027 * -3.67x
Enterprise Value 41.54M 29.47M 26.43M 24.15M 22.05M 2.77B 42.85M 291M 116M 1.48B 111M 108M 4.67B EV / Sales 2026 *
-
EV / Sales 2027 * 16.6x
Free-Float
89.49%
Yield 2026 *
-
Yield 2027 * -
1 day+4.76%
1 week+4.76%
Current month+4.76%
1 month-8.33%
3 months-4.35%
6 months-35.29%
Current year-15.38%
1 week 0.1
Extreme 0.1
0.12
1 month 0.1
Extreme 0.1
0.12
Current year 0.08
Extreme 0.085
0.2
1 year 0.08
Extreme 0.085
0.2
3 years 0.08
Extreme 0.085
0.77
5 years 0.08
Extreme 0.085
2.22
10 years 0.08
Extreme 0.085
2.87
Manager TitleAgeSince
Chief Executive Officer 59 2024-08-11
Director of Finance/CFO - 2023-10-31
Director of Finance/CFO 61 2024-10-06
Director TitleAgeSince
Chairman 59 2025-06-01
Director/Board Member 55 2025-01-09
Chairman 75 2025-09-21
Date Insider Type Main position Quantity % Market Cap. Importance
7/3/26 SellCompany -115,000 0.0305%
5/22/26 Option

Chairman

228,912 0.0658%
5/22/26 Option

Director

260,000 0.0748%
Change 5-day change 1-year change 3-year change Capi.($)
+4.76%+4.76%-26.67%-85.71% 29.47M
-3.23%+3.51%-13.00%+15.96% 190B
-2.90%+5.45%+10.41%+40.45% 125B
-2.75%+11.65%-8.47%+18.50% 124B
+0.96%+5.15%-37.16%+12.09% 99.31B
-1.80%+0.82%-7.52%+70.12% 63.65B
-0.78%+7.07%+19.14%-17.27% 57.71B
+0.79%+22.65%-4.57%+60.02% 53.26B
-6.98%-14.56%-11.97%+46.23% 47.03B
-2.36%+3.72%+3.86%-7.99% 36.15B
Average -1.43%+5.74%-7.60%+15.24% 79.62B
Weighted average by Cap. -2.20%+5.71%-7.49%+25.27%

Financials

2026 *2027 *
Net sales - 2.5M 1.77M 1.59M 1.45M 1.33M 167M 2.58M 17.52M 6.99M 88.95M 6.66M 6.51M 281M
Net income -11.3M -8.02M -7.19M -6.57M -6M -753M -11.66M -79.19M -31.58M -402M -30.09M -29.44M -1.27B -13.9M -9.86M -8.84M -8.08M -7.38M -927M -14.34M -97.42M -38.84M -495M -37.01M -36.22M -1.56B
Net Debt - -
Projected Income Statement - Annual - Sernova Biotherapeutics Inc
Logo Sernova Biotherapeutics Inc
Sernova Biotherapeutics Inc. is a Canada-based clinical-stage company, which is focused on developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cell-derived cell therapies to create bio-hybrid organs to treat chronic diseases. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.
Employees
8
Date Price Change Volume
26-11-06 $0.1100 +4.76% 32,010
26-11-05 $0.1050 0.00% 12,124
26-11-04 $0.1050 -8.70% 98,464
26-11-03 $0.1150 +15.00% 149,829
26-11-02 $0.1000 -4.76% 39,444
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.1100CAD
Average target price
1.000CAD
Spread / Average Target
+809.09%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sernova Biotherapeutics Inc